Published in J Lab Clin Med on September 01, 1980
Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. Br J Exp Pathol (1984) 0.95
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med (1989) 2.94
Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis (1999) 2.38
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
The glomerular mesangium. Kidney Int (1980) 1.83
Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis. Yale J Biol Med (1967) 1.67
Mechanism of Escherichia coli alpha-hemolysin-induced injury to isolated renal tubular cells. Am J Pathol (1987) 1.57
Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med (1993) 1.54
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients. Ann Intern Med (1994) 1.44
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int (1991) 1.42
A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine (2001) 1.41
Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids. J Clin Microbiol (1984) 1.36
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis (1983) 1.35
Cefotaxime and desacetyl cefotaxime kinetics in renal impairment. Clin Pharmacol Ther (1985) 1.34
Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? Lancet (1996) 1.34
Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int (1984) 1.29
Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Kidney Int Suppl (1997) 1.28
Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int (1990) 1.21
Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. N Engl J Med (1981) 1.21
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension (1992) 1.20
Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med (1983) 1.19
Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis (1987) 1.19
Nephron function during volume expansion in the rat. Am J Physiol (1972) 1.16
Intermittent hemodialysis in terminal chronic renal failure. Can Med Assoc J (1966) 1.14
Survival and rehabilitation of patients on home hemodialysis. Five years' experience. Ann Intern Med (1973) 1.13
Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Circ Res (1988) 1.13
Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int (1988) 1.09
Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest (1987) 1.09
Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis (1986) 1.08
Enhancement of endotoxin-induced isolated renal tubular cell injury by toxic shock syndrome toxin 1. Am J Pathol (1986) 1.04
Incidence and type of infections occurring in 445 chronic hemodialysis patients. Trans Am Soc Artif Intern Organs (1977) 1.03
Recent advances in statins and the kidney. Kidney Int Suppl (1999) 1.01
Trace elements in kidney stones from three areas in the United States. Invest Urol (1978) 1.01
Disposition of gabapentin in anuric subjects on hemodialysis. J Clin Pharmacol (1995) 0.99
Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB J (1988) 0.98
A definition of proximal and distal tubular compliance. Practical and theoretical implications. J Clin Invest (1973) 0.98
Wegener's granulomatosis and relapsing polychondritis: a case report. J Rheumatol (1981) 0.98
Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology (1985) 0.98
Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol (1987) 0.98
Unilateral Shwartzman reaction: cortical necrosis in one kidney following in vivo perfusion with endotoxin. Kidney Int (1977) 0.98
Pharmacokinetics of tazobactam M1 metabolite after administration of piperacillin/tazobactam in subjects with renal impairment. J Clin Pharmacol (1994) 0.96
Role of hypertension in progressive glomerular immune injury. Hypertension (1985) 0.96
Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med (1985) 0.96
Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Lab Invest (1985) 0.95
Protein binding of disopyramide and elevated alpha-1-acid glycoprotein concentrations in serum obtained from dialysis patients and renal transplant recipients. Am J Nephrol (1985) 0.95
Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis (1995) 0.93
Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension (1992) 0.92
Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med (1992) 0.92
Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway. Immunology (1985) 0.91
Renal complications of nonsteroidal antiinflammatory drugs: identification and monitoring of those at risk. Semin Arthritis Rheum (1985) 0.91
Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int (2001) 0.90
Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J Lab Clin Med (1985) 0.90
Lovastatin retards the progression of established glomerular disease in obese Zucker rats. Am J Kidney Dis (1993) 0.89
Catheter size as a determinant of outflow resistance and intrarenal pressure. Am J Physiol (1972) 0.89
Polyamino acid enhancement of bacterial phagocytosis by human polymorphonuclear leukocytes and peritoneal macrophages. Infect Immun (1984) 0.89
Adriamycin-induced chronic proteinuria: a structural and functional study. J Lab Clin Med (1985) 0.88
Central role of the transcription factor nuclear factor-kappa B in mesangial cell production of chemokines. Contrib Nephrol (1997) 0.88
Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest (1993) 0.87
Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun (1985) 0.87
Lipid abnormalities in end stage renal disease. Nephrol Dial Transplant (1998) 0.87
Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes. Kidney Int (1998) 0.87
Cefsulodin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother (1983) 0.86
Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin. Biochem Biophys Res Commun (2000) 0.86
Mononuclear phagocytic system stimulation. Protective role from glomerular immune complex deposition. J Lab Clin Med (1981) 0.86
Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran. Am J Nephrol (1997) 0.86
Hyperlipidemia in the nephrotic syndrome. N Engl J Med (1990) 0.86
Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis (1998) 0.85
Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int (2001) 0.85
Determinants of glomerular filtration and plasma flow in experimental diabetic rats. J Lab Clin Med (1981) 0.85
The central role of nuclear factor-kappa B in mesangial cell activation. Kidney Int Suppl (1999) 0.85
Perinephric abscess in patients with polycystic kidney disease undergoing chronic hemodialysis. Nephron (1979) 0.85
Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing. Antimicrob Agents Chemother (1989) 0.85
Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells. Nephrol Dial Transplant (1996) 0.85
Impaired mesangial clearance of macromolecules in rats with chronic mesangial ferritin-antiferritin immune complex deposition. Lab Invest (1980) 0.85
The effect of brain extracts on urinary sodium excretion of the rat and the intracellular sodium concentration of renal tubule fragments. Clin Sci Mol Med (1974) 0.85
Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians. Clin Nephrol (1996) 0.84
Lipids and progressive renal disease: the cardio-renal link. Am J Kidney Dis (1999) 0.84
The national epidemic of chronic kidney disease. What we know and what we can do. Postgrad Med (2001) 0.84
Glomerular mesangium: its function and relationship to angiotensin II. Am J Med (1985) 0.83
Lipophilic statins induce apoptosis of human vascular smooth muscle cells. Kidney Int Suppl (1999) 0.83
Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney Int (1989) 0.82
The assessment of risk factors in 462 patients with acute renal failure. Am J Kidney Dis (1985) 0.81
Intestinal and hepatic cholesterol synthesis in the alloxan diabetic rat. Proc Soc Exp Biol Med (1982) 0.81
Hemodialysis elimination rates and clearance of gentamicin and tobramycin. Antimicrob Agents Chemother (1984) 0.81
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease. Antimicrob Agents Chemother (1992) 0.81
Radiation-induced renal disease. A clinicopathologic study. Am J Med (1976) 0.81
Idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E. Kidney Int (1984) 0.81
Glucose-induced increases in renal hemodynamic function. Possible modulation by renal prostaglandins. Diabetes (1985) 0.80
Irreversible acute renal failure in idiopathic nephrotic syndrome. Am J Med (1976) 0.80
Hyperkalemia provoked by acute hepatic necrosis. Am J Nephrol (1986) 0.80
Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. Kidney Int (1995) 0.80
Lipids in progression of renal disease. Kidney Int Suppl (1997) 0.80
Cefsulodin pharmacokinetics during hemodialysis. Trans Am Soc Artif Intern Organs (1982) 0.80
Glomerular permeability to neutral and anionic dextrans in experimental diabetes. Kidney Int (1982) 0.79